Consonance Capital

Consonance Capital Management as of Sept. 30, 2014

Portfolio Holdings for Consonance Capital Management

Consonance Capital Management holds 26 positions in its portfolio as reported in the September 2014 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
United Therapeutics Corporation (UTHR) 13.4 $98M 762k 128.65
Enanta Pharmaceuticals (ENTA) 8.7 $63M 1.6M 39.57
Taro Pharmaceutical Industries (TARO) 6.6 $48M 311k 153.86
Cardiovascular Systems 6.3 $46M 1.9M 23.63
Auxilium Pharmaceuticals 6.1 $45M 1.5M 29.85
Orthofix International Nv Com Stk 6.1 $45M 1.4M 30.96
Insys Therapeutics 6.0 $43M 1.1M 38.78
Akorn 5.8 $43M 1.2M 36.27
Abbvie (ABBV) 4.6 $33M 579k 57.76
Hyperion Therapeutics 4.4 $32M 1.3M 25.22
Pernix Therapeutics Holdings 3.6 $26M 3.4M 7.68
Anacor Pharmaceuticals In 3.5 $25M 1.0M 24.47
BioScrip 3.0 $22M 3.2M 6.91
HMS Holdings 2.9 $21M 1.1M 18.85
Osiris Therapeutics 2.7 $20M 1.6M 12.59
Biosante Pharmaceuticals (ANIP) 2.1 $16M 550k 28.28
Relypsa 1.9 $14M 661k 21.09
Retrophin 1.9 $14M 1.5M 9.02
Merrimack Pharmaceuticals In 1.9 $14M 1.5M 8.78
Derma Sciences 1.7 $13M 1.5M 8.33
Protalix BioTherapeutics 1.7 $12M 5.0M 2.42
Healthways 1.5 $11M 698k 16.02
Adma Biologics (ADMA) 1.1 $8.0M 777k 10.30
IGI Laboratories 0.9 $6.7M 719k 9.32
Aastrom Biosciences 0.9 $6.7M 2.4M 2.85
HealthStream (HSTM) 0.6 $4.2M 174k 24.01